We noted the most interesting blog by Don Dizon [1] regarding the potential pulmonary toxicity induced by one (or a combination of several) of the fifteen herbal supplements taken by his patient. To illustrate the real and serious toxicity of such supplements, which are commonly available and unregulated by federal agencies, we present a case of severe hepatic toxicity associated with kratom, a plant derivative of increasing use as an alternative psychostimulant. A 23-year-old male presented to the emergency department with 4 days of painless jaundice, light stools, and dark urine, 1 week after last consuming kratom, a legally available psychoactive extract from the Mitragyna speciosa plant. He began ingesting a powdered form of kratom 6 weeks prior, consuming an estimated 85 grams in total. He denied exposure to toxins or medications, other than moderate alcohol and marijuana consumption. Total bilirubin was 7.4 mg/dL, direct bilirubin 5.8 mg/dL, ALKP 225 U/L, ALT 210 U/L, and AST 129 U/L. His INR was 0.9 and albumin 4.6 g/dL. White blood cell count was 5.6 K/uL, with 8% eosinophils. Serologies and viral molecular tests for infectious and autoimmune hepatitis were negative. Liver biopsy was entirely consistent with cholestatic liver injury. His recovery over a 2-week period was uneventful, with a return to normal liver function.
